血红素氧合酶基因的调控

血红素氧合酶(HO)是血红素分解代谢的主要酶类,有三种同工异构酶HO-1、HO-2、HO-3,不同哺乳动物的HO-1之间及HO-2之间均有很大的同源性。HO-1可以被诸多因素诱导,分子量32kD左右。HO-1与血红素结合的中心配基为His^25。HO-2分子量36kD左右,主要存在于脑及精巢中。HO-2与血红素结合的中心配基为His^25。HO-2的5′端非翻译区有少量的调节序列,其中最主要的是糖皮质激素反应元件(GRE)。HO-3的调控目前尚不清楚,初步研究提示相关多肽及其氨基酸序列调节HO-3的表达。     

植物血红素加氧酶研究进展

本文综述了血红素加氧酶（HO）的催化机理、结构特征、遗传学突变体以及在光敏色素发色团合成、调控根形态发生和参与植物对非生物胁迫应答中的作用及信号转导。同时,介绍了紫外线和盐胁迫等逆境条件以及生长素和脱落酸等植物激素对HO基因表达调控等方面的研究进展。     

植物血红素加氧酶生理功能研究进展(综述)

血红素加氧酶（heme oxygenase, HO）是血红素分解代谢的关键酶类,在植物体内起着重要的作用。本文从HO在植物光敏色素合成中的作用、对植物根形态建成、提高植物抗胁迫反应能力、促进植物种子萌发和调节植物气孔关闭等方面,综述植物HO生理功能的最新研究进展,并对HO未来研究方向进行展望。     

血红素加氧酶系统研究现状

血红素加氧酶(HO)是降解血红素的微粒体酶系统,目前已确定的有3种同工酶,它们降解血红素生成一氧化碳(CO)和胆绿素,并释放出铁离子.这3种产物都有重要的生物学意义.为了探讨血红素加氧酶系统的调节机制,就这种机制及3种重要产物的功能作一综述.     

血红素加氧酶同工酶的结构与功能

血红素加氧酶(Hemeoxygenase,HO)是一种膜结合蛋白,哺乳动物体内共发现3种同工酶,HO 1、HO 2和HO 3.HO能催化血红素降解生成α 胆绿素,铁离子和CO.这些产物都有着重要的生理作用.对HO的结构和功能研究有助于人们正确认识其催化机理和生理意义.因此从HO的催化作用、HO同工酶、HO同工酶的活性部位及HO催化的区域选择性方面作一综述.     

Pro-oxidant Role of Heme Oxygenase in Mediating Glucose-induced Endothelial Cell Damage

Oxidative damage to the vascular endothelial cells may play a crucial role in mediating glucose-induced cellular dysfunction in chronic diabetic complications. The present study was aimed at elucidating the role of glucose-induced alteration of highly inducible heme oxygenase (HO) in mediating oxidative stress in the vascular endothelial cells. We have also investigated the interaction between HO and the nitric oxide (NO) system, and its possible role in alteration of other vasoactive factors.

Human umbilical vein endothelial cells (HUVECs) were exposed to low (5?mmol/l) and high (25?mmol/l) glucose levels. In order to determine the role of HO in endothelial dysfunction and to elucidate a possible interaction between the HO and NO systems, cells were exposed to HO inducer (hemin, 10?μmol/l), HO antagonist (SnPPIX, 10?μmol/l), and NO synthase blocker (l-NAME, 200?μmol/l) with or without NO donor (arginine, 1?mmol/l). mRNA expression of HO and NO isoforms was measured by real time RT-PCR. HO activity was measured by bilirubin production and cellular oxidative stress was assessed by 8-hydroxy-2′-deoxyguanosine (8-OHdG) and nitrotyrosine staining. We also determined the expression of vasoactive factors, endothelin-1 (ET-1) and vascular endothelial growth factor (VEGF).

In the endothelial cells, glucose caused upregulation of HO-1 expression and increased HO activity. A co-stimulatory relationship between HO and NO was observed. Increased HO activity also associated with oxidative DNA and protein damage in the endothelial cells. Furthermore, increased HO activity augmented mRNA expression of vasoactive factors, ET-1 and VEGF. These data suggest that HO by itself and via elaboration of other vasoactive factors may cause endothelial injury and functional alteration. These findings are of importance in the context of chronic diabetic complications.     

血红素加氧酶系的共固定化及部分性质研究

为了检测血红素加氧酶系分子间的相互作用和共固定化酶系的反应动力学,利用２′,５′－ＡＤＰ－Ｓｅｐｈａｒｏｓｅ４Ｂ柱对血红素加氧酶、ＮＡＤＰＨ－细胞色素ｃ还原酶和胆绿素还原酶进行非膜重组,再以纤维素为载体,用重氮化法固定此重组的酶复合物和共固定非重组的３种酶,发现固定化的重组酶系比非重组酶系能更好地发挥协同作用,在室温条件下可催化血红素一步合成胆红素．共固定化酶的最适ｐＨ为７．２,最适温度为３８℃,Ｋｍ值为０．９３μｍｏｌ／Ｌ．巯基试剂和金属卟淋对固定化酶有抑制作用,共固定化酶比游离酶系稳定性提高,３８℃下的操作半寿期可延长至４２０ｈ,在０～４℃保存两个月其酶活力无明显变化．     

Impairment of Nitric Oxide Synthase but Not Heme Oxygenase Accounts for Baroreflex Dysfunction Caused by Chronic Nicotine in Female Rats

We recently reported that chronic nicotine impairs reflex chronotropic activity in female rats. Here, we sought evidence to implicate nitric oxide synthase (NOS) and/or heme oxygenase (HO) in the nicotine-baroreflex interaction. Baroreflex curves relating changes in heart rate to increases (phenylephrine) or decreases (sodium nitroprusside) in blood pressure were generated in conscious female rats treated with nicotine or saline in absence and presence of pharmacological modulators of NOS or HO activity. Compared with saline-treated rats, nicotine (2 mg/kg/day i.p., for 14 days) significantly reduced the slopes of baroreflex curves, a measure of baroreflex sensitivity (BRS). Findings that favor the involvement of NOS inhibition in the nicotine effect were (i) NOS inhibition (N _ω-Nitro-L-arginine methyl ester, L-NAME) reduced BRS in control rats but failed to do so in nicotine-treated rats, (ii) L-arginine, NO donor, reversed the BRS inhibitory effect of nicotine. Alternatively, HO inhibition (zinc protoporphyrin IX, ZnPP) had no effect on BRS in nicotine- or control rats and failed to reverse the beneficial effect of L-arginine on nicotine-BRS interaction. Similar to female rats, BRS was reduced by L-NAME, but not ZnPP, in male rats and the L-NAME effect was not accentuated after concomitant administration of nicotine. Baroreflex dysfunction caused by nicotine in female rats was blunted after supplementation with hemin (HO inducer) but not tricarbonyldichlororuthenium(II) dimer (CORM-2), a carbon monoxide (CO) releasing molecule, or bilirubin, the breakdown product of heme catabolism. The facilitatory effect of hemin was abolished upon simultaneous treatment with L-NAME or 1H-[1], [2], [4] oxadiazolo[4,3-a] quinoxalin-1-one (inhibitor of soluble guanylate cyclase, sGC). The activities of HO and NOS in brainstem tissues were also significantly increased by hemin. Thus, the inhibition of NOS, but not HO, accounts for the baroreflex depressant of chronic nicotine. Further, hemin alleviates the nicotine effect through a mechanism that is NOS/sGC but not CO or bilirubin-dependent.     

Expression of Heme Oxygenase Isozyme mRNAs in the Human Brain and Induction of Heme Oxygenase-1 by Nitric Oxide Donors

Abstract: Heme oxygenase is an essential enzyme in the heme catabolism that produces carbon monoxide (CO). This study was designed to examine the expression of two heme oxygenase isozyme mRNAs in the human brain and to explore the involvement of nitric oxide (NO) and various neuropeptides in the regulation of their expression. Northern blot analysis showed the expression of heme oxygenase-1 and heme oxygenase-2 mRNAs in every region of the brain examined, with the highest levels found in the frontal cortex, temporal cortex, occipital cortex, and hypothalamus. In a human glioblastoma cell line, T98G, treatment with any of three types of NO donors—sodium nitroprusside, 3-morpholinosydnonimine, and S -nitroso- l -glutathione—caused a significant increase in the levels of heme oxygenase-1 mRNA but not in the levels of heme oxygenase-2 and heat-shock protein 70 mRNAs. Sodium nitroprusside increased the levels of heme oxygenase-1 protein but not the levels of heat-shock protein 70 in T98G cells. The increase in content of heme oxygenase-1 mRNA caused by sodium nitroprusside was completely abolished by the treatment with actinomycin D. On the other hand, the levels of heme oxygenase isozyme mRNAs were not noticeably changed in T98G cells following the treatment with 8-bromo cyclic GMP, sodium nitrite, or various neuropeptides, such as calcitonin gene-related peptide, endothelin-1, and corticotropin-releasing hormone. The present study has shown the expression profiles of heme oxygenase-1 and -2 mRNAs in the human brain and the induction of heme oxygenase-1 mRNA caused by NO donors in T98G cells. These findings raise a possibility that the CO/heme oxygenase system may function in concert with the NO/NO synthase system in the brain.     

人血红素加氧酶同工酶的分离纯化初报

首次报道了人肝脏血红素加氧酶（hemeoxggenase,HO）的同工酶的分离纯化,并初步探讨了它们的性质．采用DEAE-SephadexA-25和羟基磷灰石柱层析法从人肝脏分离纯化H0的同工酶,酶活性检测、SDS-PAGE分析结果显示,人肝脏微粒体含HO的同工酶,按洗脱先后顺序分别得到分子量为30000和36000的HO-1和HO-2．酶促反应中需相同辅酶参与,其中酶活性HO-1明显高于HO-2,两者之比为2.4:1,从分子量和酶的催化活性分析发现,HO-1属诱导型的传统HO.HO-2为新发现的非诱导型HO的同工酶．     

Zinc Protoporphyrin Regulates Cyclin D1 Expression Independent of Heme Oxygenase Inhibition

Zinc protoporphyrin IX (ZnPP), an endogenous heme analogue that inhibits heme oxygenase (HO) activity, represses tumor growth. It can also translocate into the nucleus and up-regulate heme oxygenase 1 (HMOX1) gene expression. Here, we demonstrate that tumor cell proliferation was inhibited by ZnPP, whereas tin protoporphyrin (SnPP), another equally potent HO-1 inhibitor, had no effect. Microarray analysis on 128 tumorigenesis related genes showed that ZnPP suppressed genes involved in cell proliferation and angiogenesis. Among these genes, CYCLIN D1 (CCND1) was specifically inhibited as were its mRNA and protein levels. Additionally, ZnPP inhibited CCND1 promoter activity through an Sp1 and Egr1 overlapping binding site (S/E). We confirmed that ZnPP modulated the S/E site, at least partially by associating with Sp1 and Egr1 proteins rather than direct binding to DNA targets. Furthermore, administration of ZnPP significantly inhibited cyclin D1 expression and progression of a B-cell leukemia/lymphoma 1 tumor in mice by preferentially targeting tumor cells. These observations show HO independent effects of ZnPP on cyclin D1 expression and tumorigenesis.     

大鼠肝及脑组织中微粒体血红素加氧酶同工酶研究

采用离子交换层析和免疫印迹法分离、纯化和分析血红素和苯肼诱导后大鼠肝脏、脑组织.结果显示：纯化诱导后的大鼠肝脏,获得 HO-1和 HO-2,前者活性高于后者为2∶1.未诱导的大鼠肝脏仅获得HO-2,但诱导剂作用后,HO-1活性明显增加,而HO-2未见改变.HO-1和HO-2表观分子质量分别为30 ku和36 ku.诱导剂未作用的肝脏及作用的脑层析后仅获得HO-2活性的洗脱峰.免疫印迹法检测发现大鼠肝脏HO-2抗体与脑HO-2间有交叉反应,与肝脏HO-1无反应.实验表明在诱导剂作用的大鼠肝脏内含HO-1和HO-2同工酶,其中HO-1为诱导型酶.诱导剂作用的脑仅含HO-2.两种构型在表观分子质量,诱导性和免疫化学特性方面明显不同.     

高浓度葡萄糖下调INS-1细胞血红素氧合酶1表达水平的研究

目的:观察高糖毒性对大鼠胰岛细胞系INS-1细胞中血红素氧合酶1蛋白表达的损害作用,并研究信号分子刺激下细胞损伤的自我保护机制.方法:分别采用不同葡萄糖浓度孵育或葡萄糖代谢物葡萄糖胺持续孵育培养INS-1细胞,造成高糖毒性损伤,进而采用胰岛素以及核转录因子Nrf2激动剂莱芜硫烷刺激细胞保护信号机制改善损伤,蛋白印迹法检测细胞中血红素氧合酶1的表达情况.结果:高浓度葡萄糖溶液中(25 mM)孵育INS-1细胞48小时,血红素氧合酶1的表达水平较正常情况显著下降(P＜0.05).高浓度葡萄糖与葡萄糖胺共刺激对实验细胞中血红素氧合酶1的表达下调具有协同作用.胰岛素对实验细胞中血红素氧合酶1表达具有上调作用,但上调作用强度随培养环境中葡萄糖浓度的增高而降低.核转录因子Nrf2激动剂莱芜硫烷孵育处理实验细胞后,胞内血红素氧合酶1表达水平在葡萄糖胺刺激下上调,且与培养环境中葡萄糖浓度水平无关(P＜0.05).结论:高糖毒性可损害胰岛β细胞内抗氧化酶-血红素氧合酶Ⅰ的表达,而胰岛素可激活下游通路尤其是Nrf2信号通路,对抗高糖诱导的氧化应激损伤,从而保护胰岛细胞.     

Time-resolved Studies of IsdG Protein Identify Molecular Signposts along the Non-canonical Heme Oxygenase Pathway

IsdGs are heme monooxygenases that break open the tetrapyrrole, releasing the iron, and thereby allowing bacteria expressing this protein to use heme as a nutritional iron source. Little is currently known about the mechanism by which IsdGs degrade heme, although the products differ from those generated by canonical heme oxygenases. A synthesis of time-resolved techniques, including in proteo mass spectrometry and conventional and stopped-flow UV/visible spectroscopy, was used in conjunction with analytical methods to define the reaction steps mediated by IsdG from Staphylococcus aureus and their time scales. An apparent meso-hydroxyheme (forming with k = 0.6 min⁻¹, pH 7.4, 10 mm ascorbate, 10 μm IsdG-heme, 22 °C) was identified as a likely common intermediate with the canonical heme oxygenases. Unlike heme oxygenases, this intermediate does not form with added H₂O₂ nor does it convert to verdoheme and CO. Rather, the next observable intermediates (k = 0.16 min⁻¹) were a set of formyloxobilin isomers, similar to the mycobilin products of the IsdG homolog from Mycobacterium tuberculosis (MhuD). These converted in separate fast and slow phases to β-/δ-staphylobilin isomers and formaldehyde (CH₂O). Controlled release of this unusual C1 product may support IsdG''s dual role as both an oxygenase and a sensor of heme availability in S. aureus.     

血红素氧合酶HugZ组氨酸-249对组氨酸-245侧链缺失补偿的结构基础

血红素氧合酶HugZ是幽门螺旋杆菌(Helicobacter pylori)利用宿主血红素作为铁源的关键蛋白．HugZ的His245残基侧链咪唑基与血红素中心铁配位结合,是酶活中心的重要组成部分．用定点突变的方法构建HugZ突变体H245A、H249A和H245A/H249A基因,并将突变体蛋白表达纯化．通过X射线晶体学途径解析了突变体H245A与血红素复合物的2.55Å分辨率晶体结构．结构解析表明,HugZ的His249残基侧链咪唑基团与血红素的铁原子结合,从而补偿了His245侧链缺失．这种结构特征在已知血红素氧合酶中未曾发现．Val238 ψ平面的可翻转和Gly239的柔性是His249能与血红素配位结合的关键原因,二者的共同作用改变了C端肽链的走向,使Val238与His249之间的柔性回折与α1螺旋的相互作用发生解离,并向远离血红素的方向伸展．HugZ蛋白与血红素结合的光谱实验证明HugZ柔性C端上的组氨酸残基有利于HugZ与血红素的结合．研究结果表明,含多个组氨酸残基柔性C端的存在有利于血红素氧合酶HugZ结合和分解血红素．     

Ferulic Acid Improves Cognitive Skills Through the Activation of the Heme Oxygenase System in the Rat

Over the last years, many studies reported on the antioxidant effects of ferulic acid (FA) in preclinical models of dementia through the activation of the heme oxygenase/biliverdin reductase (HO/BVR) system. However, only a few studies evaluated whether FA could improve neurological function under milder conditions, such as psychological stress. The aim of this study was to investigate the effects of FA (150 mg/kg intraperitoneal route) on cognitive function in male Wistar rats exposed to emotional arousal. Animals were randomly assigned to two experimental groups, namely not habituated or habituated to the experimental context, and the novel object recognition test was used to evaluate their cognitive performance. The administration of FA significantly increased long-term retention memory in not habituated rats. Ferulic acid increased the expression of HO-1 in the hippocampus and frontal cortex of not habituated rats only, whereas HO-2 resulted differently modulated in these cognitive brain areas. No significant effects on either HO-1 or HO-2 or BVR were observed in the cerebellum of both habituated and not habituated rats. Ferulic acid activated the stress axis in not habituated rats, as shown by the increase in hypothalamic corticotrophin-releasing hormone levels. Pre-treatment with Sn-protoporphyrin-IX [0.25 μmol/kg, intracerebroventricular route (i.c.v.)], a well-known inhibitor of HO activity through which carbon monoxide (CO) and biliverdin (BV) are generated, abolished the FA-induced improvement of cognitive performance only in not habituated rats, suggesting a role for HO-derived by-products. The CO-donor tricarbonyldichlororuthenium (II) (30 nmol/kg i.c.v.) mimicked the FA-related improvement of cognitive skills only in not habituated rats, whereas BV did not have any effect in any group. In conclusion, these results set the stage for subsequent studies on the neuropharmacological action of FA under conditions of psychological stress.     

The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes

The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-α, IL-6, IL-1β, macrophage-inflammatory-protein-1α (MIP-1α) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-β1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-α, IL-6, IL-1β, MIP-1α and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology.